AKTX

Akari Therapeutics
AKTX

10 hedge funds and large institutions have $536K invested in Akari Therapeutics in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

less ownership

Funds ownership: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
10
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$99.1K
2
+$2.95K
3
+$148
4
Morgan Stanley
Morgan Stanley
New York
+$6

Top Sellers

1
-$48.1K
2
-$43.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$259K
2
$99.1K
3
$69.7K
4
$54.3K
5
$53.3K
6
$442
7
$295
8
$148
9
$24
10
$13
11
–
12
–